Score gout probability using the ACR/EULAR 2015 classification criteria with serum urate levels, joint involvement, and imaging findings.
The Gout Diagnosis Scoring Calculator implements the 2015 ACR/EULAR classification criteria for gout, providing a standardized, evidence-based approach to diagnosing this common inflammatory arthritis. With a prevalence of approximately 3.9% in the United States, gout is the most common form of inflammatory arthritis and is caused by the deposition of monosodium urate (MSU) crystals in joints and soft tissues.
The ACR/EULAR criteria use a weighted scoring system incorporating clinical features, laboratory results, and imaging findings to classify gout with high sensitivity (92%) and specificity (89%). A score of ≥ 8 out of a possible 23 points classifies an episode as gout. The gold standard remains MSU crystal identification in synovial fluid, which bypasses the scoring system entirely.
This calculator evaluates all scoring domains: joint pattern and involvement, clinical characteristics (acute onset, erythema, weight-bearing difficulty), laboratory values (serum urate levels), imaging findings (DECT, X-ray erosions), and crystal analysis. It provides a total score, classification, and estimated probability to structure diagnostic discussion.
This calculator standardizes gout classification using the ACR/EULAR criteria and can reduce uncertainty when joint aspiration is not available. It is most useful as a structured aid alongside clinical assessment and lab or imaging findings.
ACR/EULAR 2015 Score = Sum of weighted criteria points. Score ≥ 8 = Gout classification. Criteria include: serum urate (0–4 pts), clinical features (0–3 pts), joint pattern (0–2 pts), tophi (4 pts), imaging (0–8 pts), crystal analysis (−2 to +8 pts). Total possible: 23 points.
Result: 11 points — Gout Likely
Serum urate 8.5 mg/dL (3 pts), MTP1 involvement (2 pts), recurrent episodes (2 pts), acute onset (1 pt), erythema (1 pt), and weight-bearing difficulty (2 pts) = 11 points, above the ≥ 8 threshold for gout classification.
Gout results from the deposition of monosodium urate crystals in joints and tissues, triggered when serum urate exceeds the physiologic saturation point of approximately 6.8 mg/dL. Over time, persistent hyperuricemia leads to crystal deposition, which can trigger intense inflammatory responses mediated by the NLRP3 inflammasome and IL-1β pathway. The disease progresses through asymptomatic hyperuricemia, acute gout flares, intercritical gout, and chronic tophaceous gout.
The differential diagnosis of acute monoarticular arthritis includes septic arthritis (which must be excluded urgently), calcium pyrophosphate deposition disease (pseudogout), reactive arthritis, and traumatic arthritis. Joint aspiration with polarized light microscopy remains the gold standard for distinguishing these conditions. MSU crystals are needle-shaped and negatively birefringent, while CPPD crystals are rhomboid and positively birefringent.
This calculator is built around the ACR/EULAR classification framework, not around selecting acute or long-term therapy. Management depends on flare severity, kidney function, contraindications, crystal confirmation, and the broader rheumatology plan.
Last updated:
This worksheet tallies ACR/EULAR gout classification points to support diagnostic review. Crystal confirmation still overrides the score.
The 2015 ACR/EULAR criteria is an evidence-based scoring system that classifies gout using clinical, laboratory, and imaging findings. A score ≥ 8 (out of 23) classifies as gout with 92% sensitivity and 89% specificity.
No, but it is the gold standard. If MSU crystals are identified in synovial fluid, the diagnosis is definitive regardless of the scoring system. The scoring criteria are most useful when aspiration is not performed.
Serum urate above 6.8 mg/dL exceeds the physiologic saturation threshold and increases crystal formation risk. However, urate levels may be normal during acute flares due to inflammatory cytokine effects on renal handling.
Many guidelines discuss a serum urate target below 6 mg/dL, and sometimes below 5 mg/dL in severe tophaceous disease. This page focuses on diagnosis/classification rather than choosing long-term urate-lowering therapy.
Yes. While podagra (first MTP joint involvement) is classic, gout can affect any joint including ankles, knees, wrists, elbows, and fingers. Polyarticular gout is common in chronic disease.
Dual-energy CT (DECT) can identify urate crystal deposits non-invasively. It has high specificity (93%) for gout and is particularly useful for atypical presentations or when aspiration is not feasible.